102 related articles for article (PubMed ID: 6085381)
1. Some recent pharmacological findings with nitrendipine.
Scriabine A; Anderson CL; Janis RA; Kojima K; Rasmussen H; Lee S; Michal U
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S937-43. PubMed ID: 6085381
[TBL] [Abstract][Full Text] [Related]
2. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
Towart R
J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of Ca2+-induced constriction of isolated rabbit ear artery by nitrendipine in high K+- and/or norepinephrine-containing medium.
Scriabine A; Johnson CE; Steinsland OS; Anderson CL
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S944-8. PubMed ID: 6085382
[TBL] [Abstract][Full Text] [Related]
5. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
7. Participation of voltage-dependent calcium channels in the regulation of adrenal glomerulosa function by angiotensin II and potassium.
Aguilera G; Catt KJ
Endocrinology; 1986 Jan; 118(1):112-8. PubMed ID: 2416549
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological basis for use of calcium antagonists in hypertension.
Scriabine A; Kazda S
Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
[TBL] [Abstract][Full Text] [Related]
10. Dietary intake of sodium chloride in the rat influences [3H]nitrendipine binding to adrenal glomerulosa cell membranes but does not alter binding to vascular smooth muscle membranes.
Schiebinger RJ
J Clin Invest; 1985 Dec; 76(6):2165-70. PubMed ID: 2416776
[TBL] [Abstract][Full Text] [Related]
11. Selective enhancement of angiotensin II- and potassium-stimulated aldosterone secretion by the calcium channel agonist BAY K 8644.
Hausdorff WP; Aguilera G; Catt KJ
Endocrinology; 1986 Feb; 118(2):869-74. PubMed ID: 2417828
[TBL] [Abstract][Full Text] [Related]
12. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers: correlation among receptor binding, calcium uptake and contractility in vitro.
Papaioannou S; Panzer-Knodle S; Yang PC
J Pharmacol Exp Ther; 1987 Apr; 241(1):91-6. PubMed ID: 3572800
[TBL] [Abstract][Full Text] [Related]
14. Effects of diltiazem on calcium metabolism in cultured bovine glomerulosa cells: relationships to the actions of angiotensin II and potassium.
Kramer RE
J Pharmacol Exp Ther; 1993 Jul; 266(1):374-84. PubMed ID: 8331567
[TBL] [Abstract][Full Text] [Related]
15. Effects of N- and L-type calcium channel antagonists and (+/-)-Bay K8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands.
O'Farrell M; Ziogas J; Marley PD
Br J Pharmacol; 1997 Jun; 121(3):381-8. PubMed ID: 9179377
[TBL] [Abstract][Full Text] [Related]
16. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion.
Kojima K; Kojima I; Rasmussen H
Am J Physiol; 1984 Nov; 247(5 Pt 1):E645-50. PubMed ID: 6208793
[TBL] [Abstract][Full Text] [Related]
18. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
[TBL] [Abstract][Full Text] [Related]
19. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
[TBL] [Abstract][Full Text] [Related]
20. Calcium antagonists and excitation of the vascular muscle membrane.
Hermsmeyer K; Kuthe C
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S933-6. PubMed ID: 6085380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
